Towards minimizing immunosuppression in pediatric liver transplant recipients
- 6 July 2009
- journal article
- Published by Wiley in Pediatric Transplantation
- Vol. 13 (5) , 553-559
Abstract
Abstract: Immunosuppression regimens after liver transplantation focus mainly on preventing rejection and subsequent graft loss. However, in children, morbidity and mortality rates from infections exceed those from rejection after transplant, and immunosuppression can hinder growth, renal function, and graft tolerance. We hypothesized that early steroid withdrawal, with a primary aim of TAC monotherapy would yield no penalty in terms of rejection and graft loss, while reducing risks of infection and maximizing growth. We prospectively evaluated 64 consecutive pediatric liver transplant recipients. One yr patient/graft survival was 93/90%, respectively. At one yr post‐transplant, 75.4% of patients were on TAC monotherapy. No deaths or graft losses were caused by infection. Sixty‐one percent of patients had at least one episode of rejection, most within three months following transplant and 3.8% were treated for chronic rejection. One non‐compliant adolescent died from chronic rejection. CMV, EBV, and lymphoproliferative disease rates were 3.1%, 5.3%, 1.8%, respectively. Pretransplant and one yr post‐transplant glomerular filtration rates were unchanged. One yr improved catch‐up growth was observed. We conclude that immunosuppression minimization after pediatric liver transplant yields no serious complications from rejection, and might confer advantages with respect to infection, renal function, growth, and is deserving of wider application and study.Keywords
This publication has 37 references indexed in Scilit:
- Risk Factors for Rejection and Infection in Pediatric Liver TransplantationAmerican Journal of Transplantation, 2007
- Predictors of Outcomes after Pediatric Liver Transplantation: An Analysis of More Than 800 Cases Performed at a Single InstitutionJournal of the American College of Surgeons, 2007
- Clinical tolerance following liver transplantation: Long term results and future prospectsTransplant Immunology, 2007
- Clinical, immunological, and pathological aspects of operational tolerance after pediatric living-donor liver transplantationTransplant Immunology, 2007
- High prevalence of renal dysfunction in long-term survivors after pediatric liver transplantationThe Journal of Pediatrics, 2006
- Long‐term glomerular filtration rate following pediatric liver transplantionPediatric Transplantation, 2005
- Studies of Pediatric Liver Transplantation 2002: Patient and graft survival and rejection in pediatric recipients of a first liver transplant in the United States and CanadaPediatric Transplantation, 2004
- The effect of long‐term calcineurin inhibitor therapy on renal function in children after liver transplantationPediatric Transplantation, 2004
- LONG-TERM SURVIVAL AND RENAL FUNCTION FOLLOWING LIVER TRANSPLANTATION IN PATIENTS WITH AND WITHOUT HEPATORENAL SYNDROMETransplantation, 1991
- SERIAL DECREASE IN GLOMERULAR FILTRATION RATE IN LONG-TERM PEDIATRIC LIVER TRANSPLANTATION SURVIVORS TREATED WITH CYCLOSPORINETransplantation, 1989